-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Under the background of the new crown pandemic, no matter what industry it is, there are always voices about salary cuts and layoffs
Pfizer expects to reduce its U.
Biogen has issued layoff notices to some U.
Gilead plans to lay off 114 employees at the headquarters of the acquired Immunomedics company in three batches, with the specific layoffs being April, September and December 2022
In addition, according to the official account of Medical Cube invest, Huizhi, Merck, and GSK will reduce the number of employees by more than 5,000 in 2021
In November 2020, the Mylan and Pfizer Upjohn divisions merged to form Huizhi
Merck's revenue in 2021 is US$48.
GSK's 2021 revenue of $46.
Sanofi's net income in 2021 was 37.
Generic drug giant Teva’s revenue in 2021 was US$15.
Novartis' 2021 revenue of $51.